Oncotelic Therapeutics, Inc.·4

May 31, 9:39 AM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed May 31, 2023

Insider Transaction Report

Form 4
Period: 2023-05-26
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2023-05-26$0.03/sh+126,888$4,32791,044,217 total
Holdings
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384
  • Common Stock

    (indirect: By Spouse)
    6,872,529

Documents

1 file
  • 4
    ownership.xmlPrimary